Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

ICL Organ.Dairy Prod

₹39.7 0 | 0%

Market Cap ₹24 Cr.

Stock P/E

P/B 2

Current Price ₹39.7

Book Value ₹ 19.6

Face Value 10

52W High ₹72.4

Dividend Yield 0%

52W Low ₹ 32.9

ICL Organ.Dairy Prod Research see more...

Overview Inc. Year: 2013Industry: Consumer Food

ICL Organ.Dairy Prod Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

ICL Organ.Dairy Prod Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

ICL Organ.Dairy Prod Profit & Loss

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
Net Sales 3 12 16 5 4 4
Other Income 0 0 0 0 0 0
Total Income 3 12 16 5 4 4
Total Expenditure 2 12 15 4 3 3
Operating Profit 0 0 0 0 0 0
Interest 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 0
Provision for Tax 0 0 0 0 0 0
Profit After Tax 0 0 0 0 0 0
Adjustments 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 0
Adjusted Earnings Per Share 33.6 232.9 1.6 0.4 0.2 0.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% -37% 6% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -29% 19% NA% NA%
ROE Average 1% 2% 30% 34%
ROCE Average 1% 3% 8% 8%

ICL Organ.Dairy Prod Balance Sheet

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Shareholder's Funds 0 0 3 12 12 12
Minority's Interest 0 0 0 0 0 0
Borrowings 2 2 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0
Total Current Liabilities 0 1 0 0 0 0
Total Liabilities 2 3 3 12 13 13
Fixed Assets 2 2 2 3 3 3
Other Non-Current Assets 0 0 0 0 7 7
Total Current Assets 0 1 1 8 1 2
Total Assets 2 3 3 12 13 13

ICL Organ.Dairy Prod Cash Flow

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Opening Cash & Cash Equivalents 0 0 1 0 1 1
Cash Flow from Operating Activities 0 1 -1 -7 8 0
Cash Flow from Investing Activities 0 0 0 -2 -7 0
Cash Flow from Financing Activities 0 0 -0 9 0 -0
Net Cash Inflow / Outflow 0 1 -1 1 0 0
Closing Cash & Cash Equivalent 0 1 0 1 1 1

ICL Organ.Dairy Prod Ratios

# Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Earnings Per Share (Rs) 33.57 232.88 1.63 0.44 0.17 0.11
CEPS(Rs) 33.57 232.88 1.63 0.44 0.17 0.11
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 65.08 298.3 17.58 18.89 19.28 19.62
Core EBITDA Margin(%) 3.01 4.07 2.56 8.76 4.87 3.36
EBIT Margin(%) 3.01 4.07 2.56 8.76 4.87 3.36
Pre Tax Margin(%) 2.9 3.94 2.4 7.7 3.89 2.64
PAT Margin (%) 2 2.9 1.75 5.7 2.88 1.96
Cash Profit Margin (%) 2 2.9 1.75 5.7 2.88 1.96
ROA(%) 2.23 12.61 8.54 3.4 0.83 0.55
ROE(%) 51.58 128.17 16.12 3.71 0.91 0.59
ROCE(%) 3.63 19.7 13.71 5.62 1.5 1
Receivable days 0 0 0 0 0 0
Inventory Days 9.43 2.08 2.01 9.82 16.24 20.1
Payable days 0 1.33 1.8 7.44 5.44 0
PER(x) 0 0 0 39.1 120.39 155.92
Price/Book(x) 0 0 0 0.92 1.08 0.91
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 0.71 0.1 0.05 2.09 3.25 2.73
EV/Core EBITDA(x) 23.44 2.54 2.01 23.88 66.79 81.02
Net Sales Growth(%) 0 379.4 30.11 -70.3 -22.36 -2.88
EBIT Growth(%) 0 548.56 -18.11 1.5 -56.84 -32.9
PAT Growth(%) 0 593.72 -21.26 -3.46 -60.76 -33.88
EPS Growth(%) 0 593.72 -99.3 -72.87 -60.77 -33.87
Debt/Equity(x) 20.36 5.49 0 0.02 0.03 0.01
Current Ratio(x) 1.52 1.52 5.96 23.37 3.84 3.88
Quick Ratio(x) 1.17 1.44 5.46 22.95 3.37 3.36
Interest Cover(x) 26.63 30.46 15.78 8.23 4.98 4.68
Total Debt/Mcap(x) 0 0 0 0.02 0.02 0.01

ICL Organ.Dairy Prod Shareholding Pattern

# Mar 2020 Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023
Promoter 47.99 47.99 47.99 47.99 47.99 47.99 47.99
FII 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0
Public 52.01 52.01 52.01 52.01 52.01 52.01 52.01
Others 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 5.44 to 0days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 47.99%.
  • Company has a low return on equity of 2% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

ICL Organ.Dairy Prod News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....